INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2016

Saffron supplementation (30 mg/d) was linked to mid-term improvements in retinal function in patients with age-related macular degeneration.

Sixty patients with wet or dry AMD were randomized to receive oral saffron 30 mg/day or placebo for 6 months. In dry AMD, no statistically significant difference in OCT results was seen at 6 months (P = 0.282), though ERG results significantly increased between groups at 3 months (P = 0.027). In wet AMD, OCT results decreased significantly between groups at follow-up (P = 0.05), and ERG findings increased significantly at 3 months (P = 0.01), though this ERG change decreased by 6 months (P = 0.213).

Study type
Double-blind, placebo-controlled, randomized trial
Who was studied
60 patients with wet or dry age-related macular degeneration (AMD)
What was measured
OCT, ERG amplitude, and implicit time

THE PAPER

Short-term Outcomes of Saffron Supplementation in Patients with Age-related Macular Degeneration: A Double-blind, Placebo-controlled, Randomized Trial.

Lashay A, Sadough G, Ashrafi E, Lashay M, Movassat M, Akhondzadeh S. Med Hypothesis Discov Innov Ophthalmol, 2016.

PubMed 28289690 ↗

Healthy aging & longevityOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.